News & Updates
Filter by Specialty:
Chronic bronchitis symptoms hint at benefits of mepolizumab in COPD with T2 inflammation
The presence of chronic bronchitis symptoms in COPD with T2 inflammation drives a more pronounced and significant benefit from mepolizumab in terms of reducing CAT scores, as shown in a post hoc analysis pooling data from two phase III trials — METREX and METREO
Chronic bronchitis symptoms hint at benefits of mepolizumab in COPD with T2 inflammation
25 Sep 2024
Long-term benefits with molnupiravir modest at best in COVID-19 treatment
The antiviral molnupiravir confers continued but modest benefits in terms of reducing COVID-19–related symptoms up to 6 months after the index infection in a vaccinated population, according to a secondary analysis of the PANORAMIC trial.
Long-term benefits with molnupiravir modest at best in COVID-19 treatment
24 Sep 2024
Women with asthma more likely to need fertility treatment
Women with asthma have a higher likelihood of necessitating fertility treatment, according to a Danish nationwide historical cohort study presented at ERS 2024.
Women with asthma more likely to need fertility treatment
24 Sep 2024
What fuels flu, pneumococcal vaccine hesitancy in SG?
In Singapore, influenza and pneumococcal vaccination coverage remains stubbornly low. Results of two separate analysis of a cross-sectional survey shed light on this concerning trend, highlighting the roles of vaccine knowledge and attitude, healthcare professionals, and social support in influencing vaccination decisions.
What fuels flu, pneumococcal vaccine hesitancy in SG?
23 Sep 2024
Depemokimab a safe remedy for severe asthma exacerbations
Treatment with depemokimab results in a substantial decrease in exacerbations, with an acceptable safety profile, among severe asthma patients with an eosinophilic phenotype, results of the SWIFT-1 and 2 studies have shown.